Edwards Lifesciences Corp (EW)

Current ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Total current assets US$ in thousands 4,035,700 4,067,500 3,647,000 3,257,200 3,095,800 3,513,900 3,263,100 3,241,300 3,180,700 3,515,500 3,322,900 3,069,200 3,091,000 2,980,400 2,690,300 2,507,900 2,984,000 2,739,700 2,354,700 2,368,800
Total current liabilities US$ in thousands 1,195,400 1,238,900 1,157,200 1,082,000 1,022,400 917,900 969,100 949,900 1,032,300 966,500 886,200 799,000 893,900 846,300 873,200 746,900 902,400 775,800 697,000 646,500
Current ratio 3.38 3.28 3.15 3.01 3.03 3.83 3.37 3.41 3.08 3.64 3.75 3.84 3.46 3.52 3.08 3.36 3.31 3.53 3.38 3.66

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $4,035,700K ÷ $1,195,400K
= 3.38

The current ratio of Edwards Lifesciences Corp has displayed some fluctuations over the past eight quarters. The current ratio measures the company's ability to meet its short-term financial obligations using its current assets, with higher ratios indicating stronger liquidity.

From the data provided, we observe that the current ratio has been above 3.0 in all quarters, indicating that the company has a healthy liquidity position. In the latest quarter (Q4 2023), the current ratio was at 3.38, showing a slight increase from the previous quarter's 3.28.

While a current ratio above 2.0 is generally considered acceptable, Edwards Lifesciences Corp has consistently maintained a current ratio well above this threshold, reflecting its strong ability to cover short-term obligations. However, it is important to monitor any downward trends in the current ratio over time, as sustained decreases may indicate potential liquidity challenges in the future.

Overall, based on the current ratio trend observed, Edwards Lifesciences Corp appears to have a solid liquidity position, which is essential for managing short-term financial obligations effectively.


Peer comparison

Dec 31, 2023


See also:

Edwards Lifesciences Corp Current Ratio (Quarterly Data)